scholarly journals Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase 1/2 Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer

Author(s):  
Joseph Chen ◽  
Ana Ruiz‐Garcia ◽  
Leonard P. James ◽  
Gerson Peltz ◽  
Holger Thurm ◽  
...  
2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9062-9062 ◽  
Author(s):  
D. Ross Camidge ◽  
Gregory Alan Otterson ◽  
Jeffrey W. Clark ◽  
Sai-Hong Ignatius Ou ◽  
Jared Weiss ◽  
...  

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8068-8068 ◽  
Author(s):  
William Jeffery Edenfield ◽  
Donald A. Richards ◽  
Svetislava J. Vukelja ◽  
Glen J. Weiss ◽  
Cynthia A. Sirard ◽  
...  

Lung Cancer ◽  
2018 ◽  
Vol 125 ◽  
pp. 273-281 ◽  
Author(s):  
Shirish M. Gadgeel ◽  
James P. Stevenson ◽  
Corey J. Langer ◽  
Leena Gandhi ◽  
Hossein Borghaei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document